This panel, which was specifically designed for the detection of 63 known lung cancer-specific fusion genes, including ALK, RET, and ROS1 fusion genes, successfully identified SLC45A-ROS1 fusions in two patient samples (Figure 3a). This evidence concerns the gene ROS1 and lung carcinoma.